ArticleJournal of medical case reports2026
Hemoadsorption for refractory shock after amlodipine intoxication: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDihydropyridine calcium channel blockers are commonly prescribed to treat hypertension. In overdose they can induce cardiovascular collapse and multiorgan dysfunction with very lethal outcomes. Modern resin hemoadsorption devices can be useful for enhancing the elimination of these drugs in refractory cases. CASE PRESENTATION: The authors present the case of a Caucasian male in his 70 s who intentionally ingested 150 mg of amlodipine and was subsequently admitted to the intensive care unit with refractory vasoplegic shock. Drug clearance using hemoadsorption was attempted via the use of a styrene resin filter (Jafron HA230) with concurrent hemodynamic stabilization and successful patient outcome.
conclusionsThis case highlights a possible emerging role of HA therapy in mitigating toxic effects of protein and lipid-bound toxins in severe poisoning. Further research is essential to define standardized guidelines for its use in managing drug toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.